IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP V, LLC

Q4 2025 Holdings

Filed 2026-02-13 | 3 holdings | $429.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rapport Therapeutics, Inc.(RAPP)COM75383L102$216.5M7,135,23350.4%
Septerna, Inc.(SEPN)COM81734D104$173.3M6,215,59140.4%
Maze Therapeutics, Inc.(MAZE)COM578784100$39.4M950,8009.2%